Radioiodide induces apoptosis in human thyroid tissue in culture (316 views visite)
Endocrine (ISSN: 1355-008x, 1355-008xlinking), 2013 Dec; 44(3): 729-734.
Export to Esporta in BibTeX Export to Esporta in EndNote
Paper type Tipo di articolo: Journal Article,
Impact factor: 3.527, 5-year impact factor Impact factor a 5 anni: 2.675
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-84890797285&partnerID=40&md5=ae2ad6553b4d3501946571ffd78ea19b
Keywords Parole chiave: Apoptosis, Radioiodide Therapy, Thyroid, Caspase 3, Cytokeratin 18, Iodine 131, Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase, Article, Cell Count, Cell Viability, Culture Medium, Enzyme Linked Immunosorbent Assay, Human, Human Cell, Human Tissue, In Vitro Study, Priority Journal, Protein Cleavage, Thyroid Cell, Thyroid Tissue Culture, Tissue Culture Cell, Tissue Culture Technique, Cell Proliferation, Iodine Radioisotopes, Thyroid Gland, Drug Effects, Metabolism, Pharmacology, Cytology,
Affiliations Affiliazioni:
*** IBB - CNR ***
Department of Cellular and Molecular Biology and Pathology, University Federico II, 80131 Naples, Italy
Department of Medicine and Surgery, University of Salerno, Via Allende, 84081 Baronissi Salerno, Italy
Department of Clinical Medicine and Surgery, University Federico II, 80131 Naples, Italy
National Cancer Institute, Fondazione G. Pascale, Naples, Italy
Department of Biomorphological and Functional Sciences, University of Naples Federico II, 80131 Naples, Italy
Department of Endocrinology, Research Center of Excellence AmbiSEN, University of Pisa, 56124 Pisa, Italy
References Riferimenti:
Bonnema, S.J., Hegedus, L., Radioiodine therapy in benign thyroid diseases: Effects, side effects, and factors affecting therapeutic outcome (2012) Endocrinol. Rev., , 10.1210/er.2012-103
Reiners, C., Hanscheid, H., Luster, M., Lassmann, M., Verburg, F.A., Radioiodine for remnant ablation and therapy of metastatic disease (2011) Nat. Rev. Endocrinol., 7 (10), pp. 589-595. , 10.1038/nrendo.2011.134 21826102 10.1038/nrendo.2011.134 1:CAS:528:DC%2BC3MXht1ajsrrK
Sawin, C.T., Becker, D.V., Radioiodine and the treatment of hyperthyroidism: The early history (1997) Thyroid, 7 (2), pp. 163-176. , 9133679 10.1089/thy.1997.7.163 1:STN:280:DyaK2s3nvFWksw%3D%3D
Wartofsky, L., Van Nostrand, D., Radioiodine treatment of well-differentiated thyroid cancer (2012) Endocrine, 42 (3), pp. 506-513. , 10.1007/s12020-012-9729-5 22733393 10.1007/s12020-012-9729-5 1:CAS:528:DC%2BC38XptFagsLk%3D
Bonnema, S.J., Fast, S., Hegedus, L., Non-surgical approach to the benign nodular goiter: New opportunities by recombinant human TSH-stimulated 131I-therapy (2012) Endocrine, 40 (3), pp. 344-353. , 10.1007/s12020-011-9542-6 10.1007/s12020-011-9542-6
Sawka, A.M., Thephamongkhol, K., Brouwers, M., Thabane, L., Browman, G., Gerstein, H.C., Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer (2004) J. Clin. Endocrinol. Metab., 89 (8), pp. 3668-3676. , 10.1210/jc.2003-03116789/8/3668 15292285 10.1210/jc.2003-031167 1:CAS:528:DC%2BD2cXmslKmsbc%3D
Vitale, M., Di Matola, T., D'Ascoli, F., Salzano, S., Bogazzi, F., Fenzi, G., Martino, E., Rossi, G., Iodide excess induces apoptosis in thyroid cells through a p53-independent mechanism involving oxidative stress (2000) Endocrinology, 141 (2), pp. 598-605. , 10650940 10.1210/en.141.2.598 1:CAS:528:DC%2BD3cXmvFCltg%3D%3D
Driessens, N., Versteyhe, S., Ghaddhab, C., Burniat, A., De Deken, X., Van Sande, J., Dumont, J.E., Corvilain, B., Hydrogen peroxide induces DNA single- and double-strand breaks in thyroid cells and is therefore a potential mutagen for this organ (2009) Endocrinol. Relat. Cancer, 16 (3), pp. 845-856. , 10.1677/ERC-09-0020 10.1677/ERC-09-0020 1:CAS:528:DC%2BD1MXht1GnurnK
Amundson, S.A., Bittner, M., Meltzer, P., Trent, J., Fornace, Jr.A.J., Induction of gene expression as a monitor of exposure to ionizing radiation (2001) Radiat. Res., 156 (5 PART 2), pp. 657-661. , 11604088 10.1667/0033-7587(2001)156[0657:IOGEAA]2.0.CO
2 1:CAS:528:DC%2BD3MXosV2ks78%3D
Turgut, B., Babul, A., Ozdemir, O., Erselcan, T., Evaluation of the cell death pathway and apoptosis-stunning effect relationship after low- and high-dose I-131 administrations in rat thyroid tissue (2006) Cancer Biother. Radiopharm., 21 (4), pp. 342-351. , 10.1089/cbr.2006.21.342 16999600 10.1089/cbr.2006.21.342 1:CAS:528:DC%2BD28XhtVSgu7jI
Yang, T., Namba, H., Hara, T., Takmura, N., Nagayama, Y., Fukata, S., Ishikawa, N., Yamashita, S., P53 induced by ionizing radiation mediates DNA end-jointing activity, but not apoptosis of thyroid cells (1997) Oncogene, 14 (13), pp. 1511-1519. , 10.1038/sj.onc.1200979 9129141 10.1038/sj.onc.1200979 1:CAS:528:DyaK2sXislKmsLs%3D
Marx, K., Moka, D., Schomacker, K., Fischer, T., Gabruk-Szostak, B., Kobe, C., Dietlein, M., Schicha, H., Cell death induced by 131-I in a differentiated thyroid carcinoma cell line in vitro: Necrosis or apoptosis? (2006) Nucl. Med. Commun., 27 (4), pp. 353-358. , 10.1097/01.mnm.0000199475.08407 16531921 10.1097/01.mnm.0000199475.08407. e2
Hershman, J.M., Okunyan, A., Rivina, Y., Cannon, S., Hogen, V., Prevention of DNA double-strand breaks induced by radioiodide-(131)I in FRTL-5 thyroid cells (2011) Endocrinology, 152 (3), pp. 1130-1135. , 10.1210/en.2010-1163 21190956 10.1210/en.2010-1163 1:CAS:528: DC%2BC3MXktVGrtro%3D
Marotta, V., Guerra, A., Zatelli, M.C., Uberti, E.D., Stasi, V.D., Faggiano, A., Colao, A., Vitale, M., BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present (2013) Clin. Endocrinol. (Oxf), , In press. doi: 10.1111/cen.12194
Mosmann, T., Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays (1983) J. Immunol. Methods, 65 (1-2), pp. 55-63. , 0022-1759(83)90303-4 6606682 10.1016/0022-1759(83)90303-4 1:STN:280:DyaL2c%2FovFSmtw%3D%3D
Young, B.A., Baker, T.G., The ultrastructure of rat thyroid glands under experimental conditions in organ culture (1982) J. Anat., 135 (PART 2), pp. 407-412. , 7174511 1:STN:280:DyaL3s%2Fot1Chtg%3D%3D
Illario, M., Cavallo, A.L., Monaco, S., Di Vito, E., Mueller, F., Marzano, L.A., Troncone, G., Vitale, M., Fibronectin-induced proliferation in thyroid cells is mediated by αvβ3 integrin through Ras/Raf-1/MEK/ERK and calcium/CaMKII signals (2005) J. Clin. Endocrinol. Metab., 90 (5), pp. 2865-2873. , 15687337 10.1210/jc.2004-1520 1:CAS:528:DC%2BD2MXkt1Wgt7c%3D
Illario, M., Amideo, V., Casamassima, A., Andreucci, M., Di Matola, T., Miele, C., Rossi, G., Vitale, M., Integrin-dependent cell growth and survival are mediated by different signals in thyroid cells (2003) J. Clin. Endocrinol. Metab., 88 (1), pp. 260-269. , 12519863 10.1210/jc.2002-020774 1:CAS:528:DC%2BD3sXkvVCjsA%3D%3D
Di Matola, T., Mueller, F., Fenzi, G., Rossi, G., Bifulco, M., Marzano, L.A., Vitale, M., Serum withdrawal-induced apoptosis in thyroid cells is caused by loss of fibronectin-integrin interaction (2000) J. Clin. Endocrinol. Metab., 85 (3), pp. 1188-1193. , 10720060 10.1210/jc.85.3.1188
Vitale, M., Casamassima, A., Illario, M., Bassi, V., Fenzi, G., Rossi, G., Cell-to-cell contact modulates the expression of the beta 1 family of integrins in primary cultures of thyroid cells (1995) Exp. Cell Res., 220 (1), pp. 124-129. , 7545127 10.1006/excr.1995.1298 1:CAS:528:DyaK2MXnvVCnsrs%3D
Sasaki, M.S., Advances in the biophysical and molecular bases of radiation cytogenetics (2009) Int. J. Radiat. Biol., 85 (1), pp. 26-47. , 10.1080/09553000802641185 19205983 10.1080/09553000802641185 1:CAS:528:DC%2BD1MXhslSnsrc%3D
Lowe, S.W., Cepero, E., Evan, G., Intrinsic tumour suppression (2004) Nature, 432 (7015), pp. 307-315. , 10.1038/nature03098 15549092 10.1038/nature03098 1:CAS:528: DC%2BD2cXpvVCjtLg%3D
Karin, M., Nuclear factor-kappaB in cancer development and progression (2006) Nature, 441 (7092), pp. 431-436. , 10.1038/nature04870 16724054 10.1038/nature04870 1:CAS:528: DC%2BD28XkvVyrsrw%3D
Levine, A.J., Momand, J., Finlay, C.A., The p53 tumour suppressor gene (1991) Nature, 351 (6326), pp. 453-456. , 10.1038/351453a0 2046748 10.1038/351453a0 1:CAS:528:DyaK3MXksVaku7g%3D
Nucera, C., Porrello, A., Antonello, Z.A., Mekel, M., Nehs, M.A., Giordano, T.J., Gerald, D., Parangi, S., B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression (2010) Proc. Natl. Acad. Sci. USA, 107 (23), pp. 10649-10654. , 10.1073/pnas.1004934107 20498063 10.1073/pnas.1004934107 1:CAS:528:DC%2BC3cXnvV2it78%3D
Chakravarty, D., Santos, E., Ryder, M., Knauf, J.A., Liao, X.H., West, B.L., Bollag, G., Fagin, J.A., Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation (2011) J. Clin. Invest, 121 (12), pp. 4700-4711. , 10.1172/JCI46382 22105174 10.1172/JCI46382 1:CAS:528:DC%2BC3MXhs1ShsLvJ
Vitale, M., Intratumor BRAFV600E heterogeneity and kinase inhibitors in the treatment of thyroid cancer: A call for participation (2013) Thyroid, , In press. doi: 10.1089/thy.2012.0614
Salzano, M., Russo, E., Postiglione, L., Guerra, A., Marotta, V., Esposito, S., Vitale, M., Interferon-gamma inhibits integrin-mediated adhesion to fibronectin and survival signaling in thyroid cells (2012) J. Endocrinol., 215 (3), pp. 439-444. , 10.1530/JOE-12-0335 23027608 10.1530/JOE-12-0335 1:CAS:528: DC%2BC38Xhsl2it7fO
Bonnema, S. J., Hegedus, L., Radioiodine therapy in benign thyroid diseases: Effects, side effects, and factors affecting therapeutic outcome (2012) Endocrinol. Rev., , 10. 1210/er. 2012-103
Sawin, C. T., Becker, D. V., Radioiodine and the treatment of hyperthyroidism: The early history (1997) Thyroid, 7 (2), pp. 163-176. , 9133679 10. 1089/thy. 1997. 7. 163 1: STN: 280: DyaK2s3nvFWksw%3D%3D
Bonnema, S. J., Fast, S., Hegedus, L., Non-surgical approach to the benign nodular goiter: New opportunities by recombinant human TSH-stimulated 131I-therapy (2012) Endocrine, 40 (3), pp. 344-353. , 10. 1007/s12020-011-9542-6 10. 1007/s12020-011-9542-6
Sawka, A. M., Thephamongkhol, K., Brouwers, M., Thabane, L., Browman, G., Gerstein, H. C., Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer (2004) J. Clin. Endocrinol. Metab., 89 (8), pp. 3668-3676. , 10. 1210/jc. 2003-03116789/8/3668 15292285 10. 1210/jc. 2003-031167 1: CAS: 528: DC%2BD2cXmslKmsbc%3D
Amundson, S. A., Bittner, M., Meltzer, P., Trent, J., Fornace, Jr. A. J., Induction of gene expression as a monitor of exposure to ionizing radiation (2001) Radiat. Res., 156 (5 PART 2), pp. 657-661. , 11604088 10. 1667/0033-7587 (2001) 156 [0657: IOGEAA] 2. 0. CO
2 1: CAS: 528: DC%2BD3MXosV2ks78%3D
Hershman, J. M., Okunyan, A., Rivina, Y., Cannon, S., Hogen, V., Prevention of DNA double-strand breaks induced by radioiodide- (131) I in FRTL-5 thyroid cells (2011) Endocrinology, 152 (3), pp. 1130-1135. , 10. 1210/en. 2010-1163 21190956 10. 1210/en. 2010-1163 1: CAS: 528: DC%2BC3MXktVGrtro%3D
Young, B. A., Baker, T. G., The ultrastructure of rat thyroid glands under experimental conditions in organ culture (1982) J. Anat., 135 (PART 2), pp. 407-412. , 7174511 1: STN: 280: DyaL3s%2Fot1Chtg%3D%3D
Sasaki, M. S., Advances in the biophysical and molecular bases of radiation cytogenetics (2009) Int. J. Radiat. Biol., 85 (1), pp. 26-47. , 10. 1080/09553000802641185 19205983 10. 1080/09553000802641185 1: CAS: 528: DC%2BD1MXhslSnsrc%3D
Lowe, S. W., Cepero, E., Evan, G., Intrinsic tumour suppression (2004) Nature, 432 (7015), pp. 307-315. , 10. 1038/nature03098 15549092 10. 1038/nature03098 1: CAS: 528: DC%2BD2cXpvVCjtLg%3D
Levine, A. J., Momand, J., Finlay, C. A., The p53 tumour suppressor gene (1991) Nature, 351 (6326), pp. 453-456. , 10. 1038/351453a0 2046748 10. 1038/351453a0 1: CAS: 528: DyaK3MXksVaku7g%3D
Endocrine (ISSN: 1355-008x, 1355-008xlinking), 2013 Dec; 44(3): 729-734.
Export to Esporta in BibTeX Export to Esporta in EndNote
Paper type Tipo di articolo: Journal Article,
Impact factor: 3.527, 5-year impact factor Impact factor a 5 anni: 2.675
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-84890797285&partnerID=40&md5=ae2ad6553b4d3501946571ffd78ea19b
Keywords Parole chiave: Apoptosis, Radioiodide Therapy, Thyroid, Caspase 3, Cytokeratin 18, Iodine 131, Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase, Article, Cell Count, Cell Viability, Culture Medium, Enzyme Linked Immunosorbent Assay, Human, Human Cell, Human Tissue, In Vitro Study, Priority Journal, Protein Cleavage, Thyroid Cell, Thyroid Tissue Culture, Tissue Culture Cell, Tissue Culture Technique, Cell Proliferation, Iodine Radioisotopes, Thyroid Gland, Drug Effects, Metabolism, Pharmacology, Cytology,
Affiliations Affiliazioni:
*** IBB - CNR ***
Department of Cellular and Molecular Biology and Pathology, University Federico II, 80131 Naples, Italy
Department of Medicine and Surgery, University of Salerno, Via Allende, 84081 Baronissi Salerno, Italy
Department of Clinical Medicine and Surgery, University Federico II, 80131 Naples, Italy
National Cancer Institute, Fondazione G. Pascale, Naples, Italy
Department of Biomorphological and Functional Sciences, University of Naples Federico II, 80131 Naples, Italy
Department of Endocrinology, Research Center of Excellence AmbiSEN, University of Pisa, 56124 Pisa, Italy
References Riferimenti:
Bonnema, S.J., Hegedus, L., Radioiodine therapy in benign thyroid diseases: Effects, side effects, and factors affecting therapeutic outcome (2012) Endocrinol. Rev., , 10.1210/er.2012-103
Reiners, C., Hanscheid, H., Luster, M., Lassmann, M., Verburg, F.A., Radioiodine for remnant ablation and therapy of metastatic disease (2011) Nat. Rev. Endocrinol., 7 (10), pp. 589-595. , 10.1038/nrendo.2011.134 21826102 10.1038/nrendo.2011.134 1:CAS:528:DC%2BC3MXht1ajsrrK
Sawin, C.T., Becker, D.V., Radioiodine and the treatment of hyperthyroidism: The early history (1997) Thyroid, 7 (2), pp. 163-176. , 9133679 10.1089/thy.1997.7.163 1:STN:280:DyaK2s3nvFWksw%3D%3D
Wartofsky, L., Van Nostrand, D., Radioiodine treatment of well-differentiated thyroid cancer (2012) Endocrine, 42 (3), pp. 506-513. , 10.1007/s12020-012-9729-5 22733393 10.1007/s12020-012-9729-5 1:CAS:528:DC%2BC38XptFagsLk%3D
Bonnema, S.J., Fast, S., Hegedus, L., Non-surgical approach to the benign nodular goiter: New opportunities by recombinant human TSH-stimulated 131I-therapy (2012) Endocrine, 40 (3), pp. 344-353. , 10.1007/s12020-011-9542-6 10.1007/s12020-011-9542-6
Sawka, A.M., Thephamongkhol, K., Brouwers, M., Thabane, L., Browman, G., Gerstein, H.C., Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer (2004) J. Clin. Endocrinol. Metab., 89 (8), pp. 3668-3676. , 10.1210/jc.2003-03116789/8/3668 15292285 10.1210/jc.2003-031167 1:CAS:528:DC%2BD2cXmslKmsbc%3D
Vitale, M., Di Matola, T., D'Ascoli, F., Salzano, S., Bogazzi, F., Fenzi, G., Martino, E., Rossi, G., Iodide excess induces apoptosis in thyroid cells through a p53-independent mechanism involving oxidative stress (2000) Endocrinology, 141 (2), pp. 598-605. , 10650940 10.1210/en.141.2.598 1:CAS:528:DC%2BD3cXmvFCltg%3D%3D
Driessens, N., Versteyhe, S., Ghaddhab, C., Burniat, A., De Deken, X., Van Sande, J., Dumont, J.E., Corvilain, B., Hydrogen peroxide induces DNA single- and double-strand breaks in thyroid cells and is therefore a potential mutagen for this organ (2009) Endocrinol. Relat. Cancer, 16 (3), pp. 845-856. , 10.1677/ERC-09-0020 10.1677/ERC-09-0020 1:CAS:528:DC%2BD1MXht1GnurnK
Amundson, S.A., Bittner, M., Meltzer, P., Trent, J., Fornace, Jr.A.J., Induction of gene expression as a monitor of exposure to ionizing radiation (2001) Radiat. Res., 156 (5 PART 2), pp. 657-661. , 11604088 10.1667/0033-7587(2001)156[0657:IOGEAA]2.0.CO
2 1:CAS:528:DC%2BD3MXosV2ks78%3D
Turgut, B., Babul, A., Ozdemir, O., Erselcan, T., Evaluation of the cell death pathway and apoptosis-stunning effect relationship after low- and high-dose I-131 administrations in rat thyroid tissue (2006) Cancer Biother. Radiopharm., 21 (4), pp. 342-351. , 10.1089/cbr.2006.21.342 16999600 10.1089/cbr.2006.21.342 1:CAS:528:DC%2BD28XhtVSgu7jI
Yang, T., Namba, H., Hara, T., Takmura, N., Nagayama, Y., Fukata, S., Ishikawa, N., Yamashita, S., P53 induced by ionizing radiation mediates DNA end-jointing activity, but not apoptosis of thyroid cells (1997) Oncogene, 14 (13), pp. 1511-1519. , 10.1038/sj.onc.1200979 9129141 10.1038/sj.onc.1200979 1:CAS:528:DyaK2sXislKmsLs%3D
Marx, K., Moka, D., Schomacker, K., Fischer, T., Gabruk-Szostak, B., Kobe, C., Dietlein, M., Schicha, H., Cell death induced by 131-I in a differentiated thyroid carcinoma cell line in vitro: Necrosis or apoptosis? (2006) Nucl. Med. Commun., 27 (4), pp. 353-358. , 10.1097/01.mnm.0000199475.08407 16531921 10.1097/01.mnm.0000199475.08407. e2
Hershman, J.M., Okunyan, A., Rivina, Y., Cannon, S., Hogen, V., Prevention of DNA double-strand breaks induced by radioiodide-(131)I in FRTL-5 thyroid cells (2011) Endocrinology, 152 (3), pp. 1130-1135. , 10.1210/en.2010-1163 21190956 10.1210/en.2010-1163 1:CAS:528: DC%2BC3MXktVGrtro%3D
Marotta, V., Guerra, A., Zatelli, M.C., Uberti, E.D., Stasi, V.D., Faggiano, A., Colao, A., Vitale, M., BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present (2013) Clin. Endocrinol. (Oxf), , In press. doi: 10.1111/cen.12194
Mosmann, T., Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays (1983) J. Immunol. Methods, 65 (1-2), pp. 55-63. , 0022-1759(83)90303-4 6606682 10.1016/0022-1759(83)90303-4 1:STN:280:DyaL2c%2FovFSmtw%3D%3D
Young, B.A., Baker, T.G., The ultrastructure of rat thyroid glands under experimental conditions in organ culture (1982) J. Anat., 135 (PART 2), pp. 407-412. , 7174511 1:STN:280:DyaL3s%2Fot1Chtg%3D%3D
Illario, M., Cavallo, A.L., Monaco, S., Di Vito, E., Mueller, F., Marzano, L.A., Troncone, G., Vitale, M., Fibronectin-induced proliferation in thyroid cells is mediated by αvβ3 integrin through Ras/Raf-1/MEK/ERK and calcium/CaMKII signals (2005) J. Clin. Endocrinol. Metab., 90 (5), pp. 2865-2873. , 15687337 10.1210/jc.2004-1520 1:CAS:528:DC%2BD2MXkt1Wgt7c%3D
Illario, M., Amideo, V., Casamassima, A., Andreucci, M., Di Matola, T., Miele, C., Rossi, G., Vitale, M., Integrin-dependent cell growth and survival are mediated by different signals in thyroid cells (2003) J. Clin. Endocrinol. Metab., 88 (1), pp. 260-269. , 12519863 10.1210/jc.2002-020774 1:CAS:528:DC%2BD3sXkvVCjsA%3D%3D
Di Matola, T., Mueller, F., Fenzi, G., Rossi, G., Bifulco, M., Marzano, L.A., Vitale, M., Serum withdrawal-induced apoptosis in thyroid cells is caused by loss of fibronectin-integrin interaction (2000) J. Clin. Endocrinol. Metab., 85 (3), pp. 1188-1193. , 10720060 10.1210/jc.85.3.1188
Vitale, M., Casamassima, A., Illario, M., Bassi, V., Fenzi, G., Rossi, G., Cell-to-cell contact modulates the expression of the beta 1 family of integrins in primary cultures of thyroid cells (1995) Exp. Cell Res., 220 (1), pp. 124-129. , 7545127 10.1006/excr.1995.1298 1:CAS:528:DyaK2MXnvVCnsrs%3D
Sasaki, M.S., Advances in the biophysical and molecular bases of radiation cytogenetics (2009) Int. J. Radiat. Biol., 85 (1), pp. 26-47. , 10.1080/09553000802641185 19205983 10.1080/09553000802641185 1:CAS:528:DC%2BD1MXhslSnsrc%3D
Lowe, S.W., Cepero, E., Evan, G., Intrinsic tumour suppression (2004) Nature, 432 (7015), pp. 307-315. , 10.1038/nature03098 15549092 10.1038/nature03098 1:CAS:528: DC%2BD2cXpvVCjtLg%3D
Karin, M., Nuclear factor-kappaB in cancer development and progression (2006) Nature, 441 (7092), pp. 431-436. , 10.1038/nature04870 16724054 10.1038/nature04870 1:CAS:528: DC%2BD28XkvVyrsrw%3D
Levine, A.J., Momand, J., Finlay, C.A., The p53 tumour suppressor gene (1991) Nature, 351 (6326), pp. 453-456. , 10.1038/351453a0 2046748 10.1038/351453a0 1:CAS:528:DyaK3MXksVaku7g%3D
Nucera, C., Porrello, A., Antonello, Z.A., Mekel, M., Nehs, M.A., Giordano, T.J., Gerald, D., Parangi, S., B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression (2010) Proc. Natl. Acad. Sci. USA, 107 (23), pp. 10649-10654. , 10.1073/pnas.1004934107 20498063 10.1073/pnas.1004934107 1:CAS:528:DC%2BC3cXnvV2it78%3D
Chakravarty, D., Santos, E., Ryder, M., Knauf, J.A., Liao, X.H., West, B.L., Bollag, G., Fagin, J.A., Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation (2011) J. Clin. Invest, 121 (12), pp. 4700-4711. , 10.1172/JCI46382 22105174 10.1172/JCI46382 1:CAS:528:DC%2BC3MXhs1ShsLvJ
Vitale, M., Intratumor BRAFV600E heterogeneity and kinase inhibitors in the treatment of thyroid cancer: A call for participation (2013) Thyroid, , In press. doi: 10.1089/thy.2012.0614
Salzano, M., Russo, E., Postiglione, L., Guerra, A., Marotta, V., Esposito, S., Vitale, M., Interferon-gamma inhibits integrin-mediated adhesion to fibronectin and survival signaling in thyroid cells (2012) J. Endocrinol., 215 (3), pp. 439-444. , 10.1530/JOE-12-0335 23027608 10.1530/JOE-12-0335 1:CAS:528: DC%2BC38Xhsl2it7fO
Bonnema, S. J., Hegedus, L., Radioiodine therapy in benign thyroid diseases: Effects, side effects, and factors affecting therapeutic outcome (2012) Endocrinol. Rev., , 10. 1210/er. 2012-103
Sawin, C. T., Becker, D. V., Radioiodine and the treatment of hyperthyroidism: The early history (1997) Thyroid, 7 (2), pp. 163-176. , 9133679 10. 1089/thy. 1997. 7. 163 1: STN: 280: DyaK2s3nvFWksw%3D%3D
Bonnema, S. J., Fast, S., Hegedus, L., Non-surgical approach to the benign nodular goiter: New opportunities by recombinant human TSH-stimulated 131I-therapy (2012) Endocrine, 40 (3), pp. 344-353. , 10. 1007/s12020-011-9542-6 10. 1007/s12020-011-9542-6
Sawka, A. M., Thephamongkhol, K., Brouwers, M., Thabane, L., Browman, G., Gerstein, H. C., Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer (2004) J. Clin. Endocrinol. Metab., 89 (8), pp. 3668-3676. , 10. 1210/jc. 2003-03116789/8/3668 15292285 10. 1210/jc. 2003-031167 1: CAS: 528: DC%2BD2cXmslKmsbc%3D
Amundson, S. A., Bittner, M., Meltzer, P., Trent, J., Fornace, Jr. A. J., Induction of gene expression as a monitor of exposure to ionizing radiation (2001) Radiat. Res., 156 (5 PART 2), pp. 657-661. , 11604088 10. 1667/0033-7587 (2001) 156 [0657: IOGEAA] 2. 0. CO
2 1: CAS: 528: DC%2BD3MXosV2ks78%3D
Hershman, J. M., Okunyan, A., Rivina, Y., Cannon, S., Hogen, V., Prevention of DNA double-strand breaks induced by radioiodide- (131) I in FRTL-5 thyroid cells (2011) Endocrinology, 152 (3), pp. 1130-1135. , 10. 1210/en. 2010-1163 21190956 10. 1210/en. 2010-1163 1: CAS: 528: DC%2BC3MXktVGrtro%3D
Young, B. A., Baker, T. G., The ultrastructure of rat thyroid glands under experimental conditions in organ culture (1982) J. Anat., 135 (PART 2), pp. 407-412. , 7174511 1: STN: 280: DyaL3s%2Fot1Chtg%3D%3D
Sasaki, M. S., Advances in the biophysical and molecular bases of radiation cytogenetics (2009) Int. J. Radiat. Biol., 85 (1), pp. 26-47. , 10. 1080/09553000802641185 19205983 10. 1080/09553000802641185 1: CAS: 528: DC%2BD1MXhslSnsrc%3D
Lowe, S. W., Cepero, E., Evan, G., Intrinsic tumour suppression (2004) Nature, 432 (7015), pp. 307-315. , 10. 1038/nature03098 15549092 10. 1038/nature03098 1: CAS: 528: DC%2BD2cXpvVCjtLg%3D
Levine, A. J., Momand, J., Finlay, C. A., The p53 tumour suppressor gene (1991) Nature, 351 (6326), pp. 453-456. , 10. 1038/351453a0 2046748 10. 1038/351453a0 1: CAS: 528: DyaK3MXksVaku7g%3D
Radioiodide induces apoptosis in human thyroid tissue in culture
Radioiodide ((131)I) is routinely used for the treatment of toxic adenoma, Graves' disease, and for ablation of thyroid remnant after thyroidectomy in patients with thyroid cancer. The toxic effects of ionizing radiations on living cells can be mediated by a necrotic and/or apoptotic process. The involvement of apoptosis in radiation-induced cell death in the thyrocytes has been questioned. The knowledge of the mechanisms that underlie the thyrocyte death in response to radiations can help to achieve a successful treatment with the lowest (131)I dose. We developed a method to study the effects of (131)I in human thyroid tissue in culture, by which we demonstrated that (131)I induces thyroid cell apoptosis. Human thyroid tissues of about 1 mm(3) were cultured in vitro and cell viability was determined up to 3 weeks by the MTT assay. Radioiodide added to the culture medium was actively taken up by the tissues. The occurrence of apoptosis in the thyrocytes was assessed by measuring the production of a caspase-cleavage fragment of cytokeratin 18 (M30) by an enzyme-linked immunoassay. Neither variation of cell number nor spontaneous apoptosis was revealed after 1 week of culture. (131)I added to the culture medium induced a dose-dependent and a time-dependent generation of M30 fragment. The apoptotic process was confirmed by the generation of caspase-3 and PARP cleavage products. These results demonstrate that (131)I induces apoptosis in human thyrocytes. Human thyroid tissue cultures may be useful to investigate the cell death pathways induced by (131)I.
Radioiodide ((131)I) is routinely used for the treatment of toxic adenoma, Graves' disease, and for ablation of thyroid remnant after thyroidectomy in patients with thyroid cancer. The toxic effects of ionizing radiations on living cells can be mediated by a necrotic and/or apoptotic process. The involvement of apoptosis in radiation-induced cell death in the thyrocytes has been questioned. The knowledge of the mechanisms that underlie the thyrocyte death in response to radiations can help to achieve a successful treatment with the lowest (131)I dose. We developed a method to study the effects of (131)I in human thyroid tissue in culture, by which we demonstrated that (131)I induces thyroid cell apoptosis. Human thyroid tissues of about 1 mm(3) were cultured in vitro and cell viability was determined up to 3 weeks by the MTT assay. Radioiodide added to the culture medium was actively taken up by the tissues. The occurrence of apoptosis in the thyrocytes was assessed by measuring the production of a caspase-cleavage fragment of cytokeratin 18 (M30) by an enzyme-linked immunoassay. Neither variation of cell number nor spontaneous apoptosis was revealed after 1 week of culture. (131)I added to the culture medium induced a dose-dependent and a time-dependent generation of M30 fragment. The apoptotic process was confirmed by the generation of caspase-3 and PARP cleavage products. These results demonstrate that (131)I induces apoptosis in human thyrocytes. Human thyroid tissue cultures may be useful to investigate the cell death pathways induced by (131)I.
Radioiodide induces apoptosis in human thyroid tissue in culture
No results. Nessun risultato. |
Radioiodide induces apoptosis in human thyroid tissue in culture
Russo M, Malandrino P, Moleti M, Vermiglio F, D'Angelo A, La Rosa G, Sapuppo G, Calaciura F, Regalbuto C, Belfiore A, Vigneri R, Pellegriti G
* Differentiated thyroid cancer in children: Heterogeneity of predictive risk factors (235 visite)
Pediatr Blood Cancer (ISSN: 1545-5009linking), 2018 Sep; 65(9): e27226-e27226.
Impact Factor: 2.513
Dettagli Esporta in BibTeX Esporta in EndNote
Pace L, Klain M, Salvatore B, Nicolai E, Zampella E, Assante R, Pellegrino T, Storto G, Fonti R, Salvatore M
* Prognostic Role of 18F-FDG PET/CT in the Postoperative Evaluation of Differentiated Thyroid Cancer Patients (358 visite)
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 2015 Feb; 40(2): 111-115.
Impact Factor: 4.278
Dettagli Esporta in BibTeX Esporta in EndNote
Pace L, Klain M, Salvatore B, Nicolai E, Zampella E, Assante R, Pellegrino T, Storto G, Fonti R, Salvatore M
* Prognostic Role Of 18f-Fluorodeoxyglucose Positron Emission Tomography/Ct In The Postoperative Evaluation Of Differentiated Thyroid Cancer Patients (235 visite)
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 2015 Feb; 40(2): 111-115.
Impact Factor: 4.278
Dettagli Esporta in BibTeX Esporta in EndNote
Gallicchio R, Giacomobono S, Capacchione D, Nardelli A, Barbato F, Nappi A, Pellegrino T, Storto G
* Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation? (333 visite)
Endocrine (ISSN: 1355-008x, 1355-008xlinking), 2013 Oct; 44(2): 426-433.
Impact Factor: 3.527
Dettagli Esporta in BibTeX Esporta in EndNote
Scalia M, Satriano C, Greca R, Stella AM, Rizzarelli E, Spina-Purrello V
* PARP-1 inhibitors DPQ and PJ-34 negatively modulate proinflammatory commitment of human glioblastoma cells (395 visite)
Neurochemical Research (ISSN: 1573-6903, 0364-3190), 2013 Jan; 38(1): 50-58.
Impact Factor: 2.551
Dettagli Esporta in BibTeX Esporta in EndNote
Tedesco I, Russo M, Bilotto S, Spagnuolo C, Scognamiglio A, Palumbo R, Nappo A, Iacomino G, Moio L, Russo GL
* Dealcoholated red wine induces autophagic and apoptotic cell death in an osteosarcoma cell line (421 visite)
Food Chem Toxicol (ISSN: 0278-6915), 2013; 60: 377-384.
Impact Factor: 2.61
Dettagli Esporta in BibTeX Esporta in EndNote
Maurea S, Imbriaco M, Mollica C, Pace L, Salvatore M
* Quantitative Imaging Characterization Of Hypersecreting Or Non-Hypersecreting Adrenal Adenomas: Comparison Between Iodine-131 Nor-Cholesterol Uptake And Magnetic Resonance Signal Intensity Ratios (254 visite)
Nuclear Medicine Communications (ISSN: 1473-5628, 0143-3636), 2011 Jun; 32(6): 535-541.
Impact Factor: 1.404
Dettagli Esporta in BibTeX Esporta in EndNote
Spina-Purrello V, Giliberto S, Barresi V, Nicoletti VG, Giuffrida Stella AM, Rizzarelli E
* Modulation of PARP-1 and PARP-2 expression by L-carnosine and trehalose after LPS and INFγ-induced oxidative stress (387 visite)
Neurochemical Research (ISSN: 0364-3190, 1573-6903), 2010 Dec; 35(12): 2144-2153.
Impact Factor: 2.608
Dettagli Esporta in BibTeX Esporta in EndNote
Palmieri C, Falcone C, Iaccino E, Tuccillo FM, Gaspari M, Trimboli F, De Laurentiis A, Luberto L, Pontoriero M, Pisano A, Vecchio E, Fierro O, Panico M, Larobina M, Gargiulo S, Costa N, Dal Piaz F, Schiavone M, Arra C, Giudice A, Palma G, Barbieri A, Quinto I, Scala G
* In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder (539 visite)
Blood (ISSN: 0006-4971, 0006-6497, 0390-6078), 2010 Jul 15; 116(2): 226-238.
Impact Factor: 10.558
Dettagli Esporta in BibTeX Esporta in EndNote
Pace L, Nicolai E, Klain M, Salvatore M
* Diagnostic value of FDG PET/CT imaging (308 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2009; 53(5): 503-512.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Castiglione M, Calafiore M, Costa L, Sortino MA, Nicoletti F, Copani A
* Group I metabotropic glutamate receptors control proliferation, survival and differentiation of cultured neural progenitor cells isolated from the subventricular zone of adult mice (399 visite)
Neuropharm (ISSN: 0028-3908, 1873-7064electronic, 0028-3908linking), 2008 Sep; 55(4): 560-567.
Impact Factor: 3.383
Dettagli Esporta in BibTeX Esporta in EndNote
Salvatore B, Paone G, Klain M, Storto G, Nicolai E, D'Amico D, Della Morte AM, Pace L, Salvatore M
* Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and 131I ablation (331 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2008 Mar; 52(1): 2-8.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Caleo O, Maurea S, Klain M, Salvatore B, Storto G, Mancini M, Pace L, Salvatore M
* Postsurgical diagnostic evaluation of patients with differentiated thyroid carcinoma: Comparison of ultrasound, iodine-131 scintigraphy and PET with fluorine-18 fluorodeoxyglucose (258 visite)
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic), 2008 Mar; 113(2): 278-288.
Impact Factor: 0.955
Dettagli Esporta in BibTeX Esporta in EndNote
Cuzzocrea S, Genovese T, Failla M, Vecchio G, Fruciano M, Mazzon E, Di Paola R, Muià C, La Rosa C, Crimi N, Rizzarelli E, Vancheri C
* Protective effect of orally administered carnosine on bleomycin-induced lung injury (381 visite)
Am J Physiol Lung Cell Mol Physiol (ISSN: 1040-0605), 2007 May; 292(5): L1095-L1095.
Impact Factor: 4.214
Dettagli Esporta in BibTeX Esporta in EndNote
Pace L, Klain M, Albanese C, Salvatore B, Storto G, Soricelli A, Salvatore M
* Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment (357 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Feb; 33(2): 179-183.
Impact Factor: 4.041
Dettagli Esporta in BibTeX Esporta in EndNote
Di Pietro C, Piro S, Tabbì G, Ragusa M, Di Pietro V, Zimmitti V, Cuda F, Anello M, Consoli U, Salinaro ET, Caruso M, Vancheri C, Crimi N, Sabini MG, Cirrone GA, Raffaele L, Privitera G, Pulvirenti A, Giugno R, Ferro A, Cuttone G, Lo Nigro S, Purrello R, Purrello F, Purrello M
* Cellular and molecular effects of protons: Apoptosis induction and potential implications for cancer therapy (478 visite)
Apoptosis (ISSN: 1360-8185), 2006 Jan; 11(1): 57-66.
Impact Factor: 3.421
Dettagli Esporta in BibTeX Esporta in EndNote
Calafiore M, Battaglia G, Zappal A, Trovato-Salinaro E, Caraci F, Caruso M, Vancheri C, Sortino MA, Nicoletti F, Copani A
* Progenitor cells from the adult mouse brain acquire a neuronal phenotype in response to β-amyloid (391 visite)
Neurobiol Aging (ISSN: 0197-4580, 1558-1497electronic, 0197-4580linking), 2006; 27(4): 606-613.
Impact Factor: 5.599
Dettagli Esporta in BibTeX Esporta in EndNote
Marrazzo A, Caraci F, Salinaro ET, Su TP, Copani A, Ronsisvalle G
* Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity (557 visite)
Neuroreport (ISSN: 0959-4965), 2005 Sep 1; 16(11): 1223-1226.
Impact Factor: 1.995
Dettagli Esporta in BibTeX Esporta in EndNote
Pace L, Klain M, Soricelli A, Albanese C, Salvatore B, Storto G, Salvatore M
* Short Term Outcome of Differentiated Thyroid Cancer Patients with Detectable Serum Thyroglobulin after Initial Treatment Receiving a Second 131-IODINE Therapy (258 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2005 Sep; 32: 179-183.
Impact Factor: 3.883
Dettagli Esporta in BibTeX Esporta in EndNote
Maurea S, Caracò C, Klain M, Mainolfi C, Salvatore M
* Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques (303 visite) (PDF 236 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2004; 48(3): 188-197.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Spalletti-cernia D, Sorrentino R, Di Gaetano S, Arciello A, Garbi C, Piccoli R, D'Alessio G, Vecchio G, Laccetti P, Santoro M
* Antineoplastic ribonucleases selectively kill thyroid carcinoma cells via caspase-mediated induction of apoptosis (357 visite)
Journal Of Clinical Endocrinology & Metabolism (ISSN: 0021-972x), 2003 Jun; 88(6): 2900-2907.
Impact Factor: 5.873
Dettagli Esporta in BibTeX Esporta in EndNote
Klain M, Maurea S, Lastoria S, Cuocolo A, Colao A, Salvatore M
Technetium-99m-tetrofosmin imaging of differentiated mixed thyroid cancer (242 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1995 Dec; 36(12): 2248-2251.
Impact Factor: 3.491
Dettagli Esporta in BibTeX Esporta in EndNote
Lakshmanan M, Reynolds JC, Del Vecchio S, Merino MJ, Norton JA, Robbins J
PELVIC RADIOIODINE UPTAKE IN A RECTAL WALL TERATOMA AFTER THYROIDECTOMY FOR PAPILLARY CARCINOMA (248 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1992 Oct; 33(10): 1848-1850.
Impact Factor: 3.491
Dettagli Esporta in BibTeX Esporta in EndNote
Camera L, Del Vecchio S, Petrillo A, Esposito G, Frasci G, Iaffaioli RV, Bianco AR, Salvatore M
Evaluation of therapeutic response using iodine-131-B72. 3 monoclonal antibody in patients with ovarian carcinoma (431 visite)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1991 Apr; 18(4): 269-273.
Impact Factor: 2.692
Dettagli Esporta in BibTeX Esporta in EndNote
Salvati AM, d'Onofrio G, Berti P, Cappabianca MP, Marsili G, De Philippis C, Cossa L, Quarantelli M, Zini G, Mango G
An assessment of the operating characteristics of Coulter Counter model S-Plus STKR (538 visite)
Haematologica (ISSN: 0390-6078, 0006-4971, 0006-6497), 1991 Mar; 76(2): 94-103.
Impact Factor: 2.56
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Camera L, Petrillo A, Esposito G, Frasci G, Iaffaioli RV, Bianco AR, Salvatore M
Clinical studies with B72. 3 in ovarian cancer and probe-guided tumor localization (373 visite)
Nucl Med Biol (ISSN: 0883-2897, 0969-8051), 1991; 18(1): 85-87.
Impact Factor: 1.042
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Mansi L, Petrillo A, Camera L, Sofia M, Marra A, Carratú L, Salvatore M
Endobronchial administration of iodine-131 B72. 3 monoclonal antibody in patients with lung cancer (262 visite)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1991; 18(2): 129-132.
Impact Factor: 2.692
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Reynolds JC, Carrasquillo JA, Blasberg RG, Neumann RD, Lotze MT, Bryant GJ, Farkas RJ, Larson SM
Local distribution and concentration of intravenously injected 131I-9. 2. 27 monoclonal antibody in human malignant melanoma (304 visite)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1989; 49(10): 2783-2789.
Impact Factor: 8.426
Dettagli Esporta in BibTeX Esporta in EndNote
28 Records (27 escludendo Abstract e Conferenze).
Impact factor totale: 97.257 (93.043 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 99.939 (95.681 escludendo Abstract e Conferenze).
Vai a fine pagina Versione per copia e incolla facile Esporta tutto in BibTeX Esporta tutto in EndNote
Russo M, Malandrino P, Moleti M, Vermiglio F, D'Angelo A, La Rosa G, Sapuppo G, Calaciura F, Regalbuto C, Belfiore A, Vigneri R, Pellegriti G
* Differentiated thyroid cancer in children: Heterogeneity of predictive risk factors (235 visite)
Pediatr Blood Cancer (ISSN: 1545-5009linking), 2018 Sep; 65(9): e27226-e27226.
Impact Factor: 2.513
Dettagli Esporta in BibTeX Esporta in EndNote
Pace L, Klain M, Salvatore B, Nicolai E, Zampella E, Assante R, Pellegrino T, Storto G, Fonti R, Salvatore M
* Prognostic Role of 18F-FDG PET/CT in the Postoperative Evaluation of Differentiated Thyroid Cancer Patients (358 visite)
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 2015 Feb; 40(2): 111-115.
Impact Factor: 4.278
Dettagli Esporta in BibTeX Esporta in EndNote
Pace L, Klain M, Salvatore B, Nicolai E, Zampella E, Assante R, Pellegrino T, Storto G, Fonti R, Salvatore M
* Prognostic Role Of 18f-Fluorodeoxyglucose Positron Emission Tomography/Ct In The Postoperative Evaluation Of Differentiated Thyroid Cancer Patients (235 visite)
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 2015 Feb; 40(2): 111-115.
Impact Factor: 4.278
Dettagli Esporta in BibTeX Esporta in EndNote
Gallicchio R, Giacomobono S, Capacchione D, Nardelli A, Barbato F, Nappi A, Pellegrino T, Storto G
* Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation? (333 visite)
Endocrine (ISSN: 1355-008x, 1355-008xlinking), 2013 Oct; 44(2): 426-433.
Impact Factor: 3.527
Dettagli Esporta in BibTeX Esporta in EndNote
Scalia M, Satriano C, Greca R, Stella AM, Rizzarelli E, Spina-Purrello V
* PARP-1 inhibitors DPQ and PJ-34 negatively modulate proinflammatory commitment of human glioblastoma cells (395 visite)
Neurochemical Research (ISSN: 1573-6903, 0364-3190), 2013 Jan; 38(1): 50-58.
Impact Factor: 2.551
Dettagli Esporta in BibTeX Esporta in EndNote
Tedesco I, Russo M, Bilotto S, Spagnuolo C, Scognamiglio A, Palumbo R, Nappo A, Iacomino G, Moio L, Russo GL
* Dealcoholated red wine induces autophagic and apoptotic cell death in an osteosarcoma cell line (421 visite)
Food Chem Toxicol (ISSN: 0278-6915), 2013; 60: 377-384.
Impact Factor: 2.61
Dettagli Esporta in BibTeX Esporta in EndNote
Maurea S, Imbriaco M, Mollica C, Pace L, Salvatore M
* Quantitative Imaging Characterization Of Hypersecreting Or Non-Hypersecreting Adrenal Adenomas: Comparison Between Iodine-131 Nor-Cholesterol Uptake And Magnetic Resonance Signal Intensity Ratios (254 visite)
Nuclear Medicine Communications (ISSN: 1473-5628, 0143-3636), 2011 Jun; 32(6): 535-541.
Impact Factor: 1.404
Dettagli Esporta in BibTeX Esporta in EndNote
Spina-Purrello V, Giliberto S, Barresi V, Nicoletti VG, Giuffrida Stella AM, Rizzarelli E
* Modulation of PARP-1 and PARP-2 expression by L-carnosine and trehalose after LPS and INFγ-induced oxidative stress (387 visite)
Neurochemical Research (ISSN: 0364-3190, 1573-6903), 2010 Dec; 35(12): 2144-2153.
Impact Factor: 2.608
Dettagli Esporta in BibTeX Esporta in EndNote
Palmieri C, Falcone C, Iaccino E, Tuccillo FM, Gaspari M, Trimboli F, De Laurentiis A, Luberto L, Pontoriero M, Pisano A, Vecchio E, Fierro O, Panico M, Larobina M, Gargiulo S, Costa N, Dal Piaz F, Schiavone M, Arra C, Giudice A, Palma G, Barbieri A, Quinto I, Scala G
* In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder (539 visite)
Blood (ISSN: 0006-4971, 0006-6497, 0390-6078), 2010 Jul 15; 116(2): 226-238.
Impact Factor: 10.558
Dettagli Esporta in BibTeX Esporta in EndNote
Pace L, Nicolai E, Klain M, Salvatore M
* Diagnostic value of FDG PET/CT imaging (308 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2009; 53(5): 503-512.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Castiglione M, Calafiore M, Costa L, Sortino MA, Nicoletti F, Copani A
* Group I metabotropic glutamate receptors control proliferation, survival and differentiation of cultured neural progenitor cells isolated from the subventricular zone of adult mice (399 visite)
Neuropharm (ISSN: 0028-3908, 1873-7064electronic, 0028-3908linking), 2008 Sep; 55(4): 560-567.
Impact Factor: 3.383
Dettagli Esporta in BibTeX Esporta in EndNote
Salvatore B, Paone G, Klain M, Storto G, Nicolai E, D'Amico D, Della Morte AM, Pace L, Salvatore M
* Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and 131I ablation (331 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2008 Mar; 52(1): 2-8.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Caleo O, Maurea S, Klain M, Salvatore B, Storto G, Mancini M, Pace L, Salvatore M
* Postsurgical diagnostic evaluation of patients with differentiated thyroid carcinoma: Comparison of ultrasound, iodine-131 scintigraphy and PET with fluorine-18 fluorodeoxyglucose (258 visite)
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic), 2008 Mar; 113(2): 278-288.
Impact Factor: 0.955
Dettagli Esporta in BibTeX Esporta in EndNote
Cuzzocrea S, Genovese T, Failla M, Vecchio G, Fruciano M, Mazzon E, Di Paola R, Muià C, La Rosa C, Crimi N, Rizzarelli E, Vancheri C
* Protective effect of orally administered carnosine on bleomycin-induced lung injury (381 visite)
Am J Physiol Lung Cell Mol Physiol (ISSN: 1040-0605), 2007 May; 292(5): L1095-L1095.
Impact Factor: 4.214
Dettagli Esporta in BibTeX Esporta in EndNote
Pace L, Klain M, Albanese C, Salvatore B, Storto G, Soricelli A, Salvatore M
* Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment (357 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Feb; 33(2): 179-183.
Impact Factor: 4.041
Dettagli Esporta in BibTeX Esporta in EndNote
Di Pietro C, Piro S, Tabbì G, Ragusa M, Di Pietro V, Zimmitti V, Cuda F, Anello M, Consoli U, Salinaro ET, Caruso M, Vancheri C, Crimi N, Sabini MG, Cirrone GA, Raffaele L, Privitera G, Pulvirenti A, Giugno R, Ferro A, Cuttone G, Lo Nigro S, Purrello R, Purrello F, Purrello M
* Cellular and molecular effects of protons: Apoptosis induction and potential implications for cancer therapy (478 visite)
Apoptosis (ISSN: 1360-8185), 2006 Jan; 11(1): 57-66.
Impact Factor: 3.421
Dettagli Esporta in BibTeX Esporta in EndNote
Calafiore M, Battaglia G, Zappal A, Trovato-Salinaro E, Caraci F, Caruso M, Vancheri C, Sortino MA, Nicoletti F, Copani A
* Progenitor cells from the adult mouse brain acquire a neuronal phenotype in response to β-amyloid (391 visite)
Neurobiol Aging (ISSN: 0197-4580, 1558-1497electronic, 0197-4580linking), 2006; 27(4): 606-613.
Impact Factor: 5.599
Dettagli Esporta in BibTeX Esporta in EndNote
Marrazzo A, Caraci F, Salinaro ET, Su TP, Copani A, Ronsisvalle G
* Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity (557 visite)
Neuroreport (ISSN: 0959-4965), 2005 Sep 1; 16(11): 1223-1226.
Impact Factor: 1.995
Dettagli Esporta in BibTeX Esporta in EndNote
Pace L, Klain M, Soricelli A, Albanese C, Salvatore B, Storto G, Salvatore M
* Short Term Outcome of Differentiated Thyroid Cancer Patients with Detectable Serum Thyroglobulin after Initial Treatment Receiving a Second 131-IODINE Therapy (258 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2005 Sep; 32: 179-183.
Impact Factor: 3.883
Dettagli Esporta in BibTeX Esporta in EndNote
Maurea S, Caracò C, Klain M, Mainolfi C, Salvatore M
* Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques (303 visite) (PDF 236 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2004; 48(3): 188-197.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Spalletti-cernia D, Sorrentino R, Di Gaetano S, Arciello A, Garbi C, Piccoli R, D'Alessio G, Vecchio G, Laccetti P, Santoro M
* Antineoplastic ribonucleases selectively kill thyroid carcinoma cells via caspase-mediated induction of apoptosis (357 visite)
Journal Of Clinical Endocrinology & Metabolism (ISSN: 0021-972x), 2003 Jun; 88(6): 2900-2907.
Impact Factor: 5.873
Dettagli Esporta in BibTeX Esporta in EndNote
Klain M, Maurea S, Lastoria S, Cuocolo A, Colao A, Salvatore M
Technetium-99m-tetrofosmin imaging of differentiated mixed thyroid cancer (242 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1995 Dec; 36(12): 2248-2251.
Impact Factor: 3.491
Dettagli Esporta in BibTeX Esporta in EndNote
Lakshmanan M, Reynolds JC, Del Vecchio S, Merino MJ, Norton JA, Robbins J
PELVIC RADIOIODINE UPTAKE IN A RECTAL WALL TERATOMA AFTER THYROIDECTOMY FOR PAPILLARY CARCINOMA (248 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1992 Oct; 33(10): 1848-1850.
Impact Factor: 3.491
Dettagli Esporta in BibTeX Esporta in EndNote
Camera L, Del Vecchio S, Petrillo A, Esposito G, Frasci G, Iaffaioli RV, Bianco AR, Salvatore M
Evaluation of therapeutic response using iodine-131-B72. 3 monoclonal antibody in patients with ovarian carcinoma (431 visite)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1991 Apr; 18(4): 269-273.
Impact Factor: 2.692
Dettagli Esporta in BibTeX Esporta in EndNote
Salvati AM, d'Onofrio G, Berti P, Cappabianca MP, Marsili G, De Philippis C, Cossa L, Quarantelli M, Zini G, Mango G
An assessment of the operating characteristics of Coulter Counter model S-Plus STKR (538 visite)
Haematologica (ISSN: 0390-6078, 0006-4971, 0006-6497), 1991 Mar; 76(2): 94-103.
Impact Factor: 2.56
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Camera L, Petrillo A, Esposito G, Frasci G, Iaffaioli RV, Bianco AR, Salvatore M
Clinical studies with B72. 3 in ovarian cancer and probe-guided tumor localization (373 visite)
Nucl Med Biol (ISSN: 0883-2897, 0969-8051), 1991; 18(1): 85-87.
Impact Factor: 1.042
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Mansi L, Petrillo A, Camera L, Sofia M, Marra A, Carratú L, Salvatore M
Endobronchial administration of iodine-131 B72. 3 monoclonal antibody in patients with lung cancer (262 visite)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1991; 18(2): 129-132.
Impact Factor: 2.692
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Reynolds JC, Carrasquillo JA, Blasberg RG, Neumann RD, Lotze MT, Bryant GJ, Farkas RJ, Larson SM
Local distribution and concentration of intravenously injected 131I-9. 2. 27 monoclonal antibody in human malignant melanoma (304 visite)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1989; 49(10): 2783-2789.
Impact Factor: 8.426
Dettagli Esporta in BibTeX Esporta in EndNote
28 Records (27 escludendo Abstract e Conferenze).
Impact factor totale: 97.257 (93.043 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 99.939 (95.681 escludendo Abstract e Conferenze).
Last modified by Ultima modifica di Marco Comerci on in data Sunday 12 July 2020, 13:14:52
316 views visite. Last view on Ultima visita in data Wednesday 14 July 2021, 21:06:44
ibb.cnr.it